Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-24 @ 11:49 PM
NCT ID:
NCT03957551
Brief Title:
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
Official Title:
Cabozantinib and Pembrolizumab as a Front-line Therapy for Advanced Metastatic Melanoma
Study:
NCT03957551
Protocol Section:
NCT03957551